Summary
The mid-cap value screen applies the exact same point-in-time price-to-book rules as US Small-Cap Value 50, but raises the minimum market-capitalisation threshold tenfold from $50 million to $500 million. Each of the 50 non-financial stocks starts at an equal 2% weight at the March and September rebalances.
From March 2006 to September 2026, the mid-cap value portfolio returned 7.1% a year with 28.7% annualised volatility, producing a 0.33 Sharpe ratio against 0.55 for the Fama–French Market Portfolio (11.2% CAGR, 19.6% volatility).
The Fama–French five-factor model explained 88% of daily return variation (R² = 0.88), with statistically indistinguishable alpha (-2.2%, p = 0.322). This side-by-side result demonstrates why capacity-constrained small-caps behave so differently from liquid mid-caps under identical screening rules.
1. Performance Through Stress: 2006–2015 (GFC & Recovery)
During the 2008–2009 financial crisis, mid-cap value experienced a drawdown nearly as severe as small-cap value, without the same post-crisis upside torque.
- Drawdown: From July 2007 to March 2009, the portfolio fell 61.8% from peak to trough, versus 54.6% for the market benchmark.
- Recovery: NAV recovered its pre-crisis peak in 12.3 months from the trough, faster than the market’s 35.7 months but slower than small-cap value’s 8.4 months.
- Factors: Five-factor
R²reached 0.94 — showing that returns closely tracked standard market (+1.12), size (+0.80), value (+0.26) and profitability (+0.13) betas. - Returns: The portfolio returned 4.9% a year with 28.3% annualised volatility (Sharpe
0.27vs.0.38market) and lost money in 9 of 20 half-year periods.
2. Modern Market Regime: 2016–2026 (COVID-19 & Rate Cycles)
The 2016–2026 decade saw an extended drawdown heading into March 2020, followed by a value rebound in 2021–2022 that still trailed mega-cap index concentration.
- Drawdown: From August 2018 to March 2020, the portfolio fell 61.0% from peak to trough, versus 34.2% for the market benchmark.
- Recovery: NAV regained its prior peak in 9.9 months, compared with 4.4 months for the market and 2.6 months for small-cap value.
- Factors: Market (
+1.13), size (+1.03) and value (+0.53) loadings were all highly significant (R² = 0.84), with-2.9%alpha (p = 0.425). - Returns: The portfolio returned 9.4% a year with 29.0% annualised volatility (Sharpe
0.38vs.0.74market), posting losses in 8 of 22 half-year periods.
Full-Sample & Regime Summary
| Metric | Full Sample (2006–2026) | 2006–2015 Regime | 2016–2026 Regime |
|---|---|---|---|
| Annualised Return | 7.1% (11.2% Mkt) | 4.9% (7.2% Mkt) | 9.4% (15.2% Mkt) |
| Annualised Volatility | 28.7% (19.6% Mkt) | 28.3% (21.0% Mkt) | 29.0% (18.3% Mkt) |
| Sharpe Ratio | 0.33 (0.55 Mkt) | 0.27 (0.38 Mkt) | 0.38 (0.74 Mkt) |
| Max Drawdown | -61.8% (-54.6% Mkt) | -61.8% (-54.6% Mkt) | -61.0% (-34.2% Mkt) |
| Post-Trough Recovery | 12.3 months (35.7m Mkt) | 12.3 months | 9.9 months (4.4m Mkt) |
| Negative Half-Year Periods | 17 / 42 | 9 / 20 | 8 / 22 |
| Fama–French 5-Factor R² | 0.88 | 0.94 | 0.84 |
| FF5 Annualised Alpha | -2.2% (p = 0.322) | -1.7% (p = 0.433) | -2.9% (p = 0.425) |
Conclusion
Mid-Cap Value 50 offers significantly higher trading capacity and tighter alignment with textbook Fama–French risk factors (R² = 0.88), but did not earn excess alpha over the 2006–2026 sample. Investors evaluating value screens should weigh trading liquidity against the empirical concentration of the value premium in smaller, less-followed issuers.